Company news

Physiomics PLC news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Confirmation of Award of Innovate UK Grant

January 6, 2017

Payment for in-silico modelling of inhibitor

December 5, 2016

Posting of Financial Results and Notice of AGM

November 23, 2016

Provisional Award of Innovate UK Grant

November 22, 2016

Final Results for the year ended 30 June 2016

October 27, 2016

Presentation at Conference on Pharmacometrics

October 26, 2016

Directorate Change

October 25, 2016

Advisor Changes

September 28, 2016

Placing and Update on Acquisition

September 21, 2016

Result of GM

September 7, 2016

Notice of General Meeting

August 22, 2016

Signing of Share Purchase Agreement with BioMoti

August 18, 2016

Extensions for Virtual Tumour Project

May 16, 2016

Appointment of part-time Head of Finance

May 3, 2016

Physiomics Appoints New Chief Executive Officer

April 18, 2016

Virtual Tumour Developments Presentation at AACR

April 6, 2016

New Speciality Pharma Customer for new Indication

April 4, 2016

Heads of Terms with BioMoti and Board Changes

March 31, 2016

New Speciality Pharma Customer for New Indication

December 22, 2015

Result of General Meeting

December 14, 2015

Strategic Update

November 6, 2015

4th Large Pharma Customer for Virtual Tumour

October 12, 2015

Project extension with global pharma company

October 9, 2015

Prof. Mark Middleton appointed to Physiomics SAB

August 4, 2015

Virtual Tumour platform - AACR Annual Meeting 2015

April 22, 2015

Half Yearly Report

March 17, 2015

First contract for clinical version of Virtu

March 3, 2015

Termination of Equity Swap Agreement

February 2, 2015

Disclosure of Large Pharma partner Merck & Co

November 4, 2014

Cardiotox Platform Launch

October 7, 2014

New deal with global pharma

August 14, 2014

Anticipated new collaboration with Diatech

June 12, 2014

Second validation of Virtual Tumour Clinical

April 10, 2014

Virtual Tumour Clinical Validation

April 3, 2014

Issue of Equity - Replacement

January 30, 2014

Dundee University Collaboration

January 16, 2014

Virtual Tumour Proposal

December 4, 2013

DrugCARD launch

November 28, 2013

University of Oxford Collaboration

November 11, 2013

Update on the Virtual Tumour Clinical platform

November 4, 2013

Drawdown pursuant to SEDA Arrngmnt/Issue of Equity

October 10, 2013

Physiomics gains new speciality pharma customer

October 7, 2013

Physiomics gains first large pharma customer

October 1, 2013

Physiomics to present cardiac toxicity platform

September 16, 2013

Additional SEDA Drawdown

July 1, 2013

Wins Poster Award

June 24, 2013

Award of Grant

June 20, 2013

Population Approach Group Europe

June 11, 2013

Virtual Tumour Clinical Contract

June 6, 2013

Physiomics to present new developments

April 8, 2013

← Newer news releases · Older news releases →

Calls

The 5 newest of 12 calls. Every call is listed under its year.

Decks

The 5 newest of 6 decks. Every deck is listed under its year.